PTPN22, a negative regulator of T cell activation, has been associated with the development of multiple autoimmune diseases, including SLE, rheumatoid arthritis, type 1 diabetes, and autoimmune thyroid disease (47). Here, PTPN22 is linked to type 1 diabetes mellitus.